Article
What the FDA flagged
In a notice posted Aug. 20, the FDA said certain Medline convenience kits contain B. Braun components that include Huons Bupivacaine Hydrochloride in Dextrose Injection, a product its manufacturer had already recalled. The affected kits are used in high-volume procedures: anterior, posterior and total hip, total knee and total joint kits, plus C-section kits.
The agency warns that compromised injectables can cause infection, an inflammatory response or weaker anesthesia, which can force an emergency switch to general anesthesia. When the drug is used in the neuraxial space, contamination could lead to meningitis. B. Braun had reported 35 serious injuries and no deaths as of April 24, and Medline reported no further serious injuries or deaths as of June 19.
This is a correction rather than a removal. Medline first notified customers on June 6 and is sending over-labels that tell staff to pull and discard the affected component before the kit is opened in a procedure. The FDA asks facilities to check stock against the listed item and lot numbers, quarantine affected kits, return the response form and pass the notice to any downstream sites.
A pattern, not an incident
On Aug. 3 the FDA classified two other kit corrections as Class I, including Medline kits tied to the same recalled Huons injection. Convenience kits bundle dozens of items from many suppliers under one catalog number. When an upstream drug or device is recalled, the problem can reach the operating room weeks later under a different label, and an item-master search for the original product name may miss it entirely.
Corrections that depend on staff applying stickers and removing a part at the point of use add risk. A busy orthopedic room or a labor and delivery unit at 3 a.m. is not the place to rely on a label being noticed.
What to check this week
- Trace components, not just kits. Ask kit suppliers for component-level bills of materials and map them to your recall system so an upstream drug recall flags every kit that contains it.
- Close the loop with pharmacy. A drug inside a device kit can fall between pharmacy and materials management. Assign one owner for kit-embedded medications.
- Verify the over-labels. Have perioperative and obstetric leaders confirm that labels were applied and that staff know to discard the component.
- Review the anesthesia plan. Make sure anesthesia teams know which lots are affected and have alternatives stocked.
Archive entry for Aug 21, 2026, added Nov. 11, 2026.